A comparative study: rural versus urban children as regard exposure to organophosphorus pesticides using cholinesterase enzyme activity

Mohamed, Yasmen A.; Meabed, Mohamed Hussien; Abougaba, Khadiga Mohamed; Sayed, Fatma Ali; Welson, Nermeen N.; Ibrahim, Raghda Ebaid

doi:10.1186/s43088-021-00190-z

Beni-Suef University Journal of Basic and Applied Sciences

Table 3 Comparison between the study groups as regard frequency of clinical symptoms

From: A comparative study: rural versus urban children as regard exposure to organophosphorus pesticides using cholinesterase enzyme activity

	Group		p
	Urban	Rural	p
Eye symptoms
Eye symptoms
No	43 (95.6%)	18 (40.0%)	< 0.001
Yes	2 (4.4%)	27 (60.0%)
Blurry or impaired vision
No	42 (93.3%)	22 (48.9%)	< 0.001
Yes	3 (6.7%)	23 (51.1%)
Watery eye
No	45 (100.0%)	24 (53.3%)	< 0.001
Yes	0 (0.0%)	21 (46.7%)
Narrowed pupils
No	45 (100.0%)	31 (68.9%)	< 0.001
Yes	0 (0.0%)	14 (31.1%)
Stinging eye
No	45 (100.0%)	26 (57.8%)	< 0.001
Yes	0 (0.0%)	19 (42.2%)
Respiratory symptoms
Respiratory symptoms
No	37 (82.2%)	27 (60.0%)	0.02
Yes	8 (17.8%)	18 (40.0%)
Runny nose
No	37 (82.2%)	29 (64.4%)	0.057
Yes	8 (17.8%)	16 (35.6%)
Sneezing
No	42 (93.3%)	30 (66.7%)	0.002
Yes	3 (6.7%)	15 (33.3%)
Cough
No	39 (86.7%)	31 (68.9%)	0.043
Yes	6 (13.3%)	14 (31.1%)
Difficult breathing
No	45 (100.0%)	32 (71.1%)	< 0.001
Yes	0 (0.0%)	13 (28.9%)
Wheezing
No	44 (97.8%)	32 (71.1%)	< 0.001
Yes	1 (2.2%)	13 (28.9%)
Cardiac symptoms
Irregular or slow heartbeats
No	45 (100%)	36 (80.0%)	0.002
Yes	0 (0.0%)	9 (20.0%)
CNS symptoms
CNS symptoms
No	41 (91.1%)	24 (53.3%)	< 0.001
Yes	4 (8.9%)	21 (46.7%)
Confusion
No	45 (100.0%)	30 (66.7%)	< 0.001
Yes	0 (0.0%)	15 (33.3%)
Convulsions
No	45 (100.0%)	45 (100.0%)
Yes	0 (0.0%)0	0 (0.0%)
Coma
No	45 (100.0%)	45 (100.0%)
Yes	0 (0.0%)0	0 (0.0%)
Headache
No	41 (91.1%)	29 (64.4%)	0.002
Yes	4 (8.9%)	16 (35.6%)
Disorientation
No	45 (100.0%)	34 (75.6%)	< 0.001
Yes	0 (0.0%)	11 (24.4%)
Muscle symptoms
Muscle symptoms
No	42 (93.3%)	19 (42.2%)	< 0.001
Yes	3 (6.7%)	26 (57.8%)
Muscle tremors
No	45 (100.0%)	37 (82.2%)	0.003
Yes	0 (0.0%)	8 (17.8%)
Muscle fatigue or weakness
No	42 (93.3%)	28 (62.2%)	< 0.001
Yes	3 (6.7%)	17 (37.8%)
Muscle twitching
No	45 (100.0%)	33 (73.3%)	< 0.001
Yes	0 (0.0%)	12 (26.7%)
GIT symptoms
GIT symptoms
No	36 (80.0%)	18 (40.0%)	< 0.001
Yes	9 (20.0%)	27 (60.0%)
Salivation
No	45 (100.0%)	38 (92.7%)	0.065
Yes	0 (0.0%)	3 (7.3%)
Nausea
No	39 (86.7%)	30 (69.8%)	0.054
Yes	6 (13.3%)	13 (30.2%)
Vomiting
No	45 (100.0%)	28 (62.2%)	< 0.001
Yes	0 (0.0%)	17 (37.8%)
Diarrhea
No	42 (93.3%)	29 (64.4%)	0.001
Yes	3 (6.7%)	16 (35.6%)
Uncontrolled bowel movement
No	43 (95.6%)	28 (65.1%)	< 0.001
Yes	2 (4.4%)	15 (34.9%)
Urinary symptoms
Uncontrolled urination
No	45 (100.0%)	41 (91.1%	0.041
Yes	0 (0.0%)	4 (8.9%)

Back to article page